Followup-- "5 questions on Trump's newest drug-pricing plan" -- 1. Will the international benchmark actually come to fruition? Skeptics doubt the Trump administration will follow through with the splashiest part of the proposal: tying Medicare Part B drug prices to foreign prices for the same drugs, which are often significantly lower. https://www.modernhealthcare.com/article/20181026/NEWS/181029926?